The Supreme Court Decision(s) in Myriad: What Did the Justices Say? What Does it Mean for Industry?

Our panelists will analyze the decision and discuss what it means for the biotechnology industry and the evolving area of patent-eligibility jurisprudence as a whole.

Featured Guest Speakers:

• The Honorable Paul R. Michel (ret.), United States Court of Appeals for the Federal Circuit


• Hans Sauer, Deputy General Counsel, BIO  


• Kevin Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP and co-founder of Patent Docs

Featured Foley Speakers:

• Moderated by Courtenay C. Brinckerhoff, Partner, Foley & Lardner LLP and editor of PharmaPatents Blog


• Hosted by Harold C. Wegner, Partner, Foley & Lardner LLP

For more information, please contact Meg Ryan at [email protected].

Foley & Lardner LLP will apply for CLE credit after the program, wherever applicable. Foley & Lardner LLP certifies that this activity has been approved for California MCLE credits by the State Bar of California in the amount of one General credit. Foley & Lardner LLP is a State Bar of California MCLE approved provider. Please note that participants must log in to both the teleconference and LiveMeeting portions on the date of the event; credit may not be obtained by viewing and/or listening to a program recording after the event.